Related Experiment Video
Updated: Jun 29, 2025
Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice
Published on: April 10, 2019
The Roles of Exosome-Derived microRNAs in Cardiac Fibrosis
Xinyuan Tang1,2,3,4, Mingyang Leng1,2,3,4, Wenyue Tang1,2,3,4
1Guangdong Metabolic Diseases Research Center of Integrated Chinese and Western Medicine, Guangzhou 510006, China.
Insights
Cardiovascular disease (CVD) and myocardial fibrosis (MF) lack effective treatments. Exosomal microRNAs (miRNAs) show promise for diagnosing and treating these conditions, offering potential biotherapies.
Area of Science:
- Cardiovascular Research
- Biotechnology
- Molecular Biology
Background:
- Cardiovascular disease (CVD) is a leading cause of mortality, exacerbated by challenges in early diagnosis and treatment.
- Myocardial fibrosis (MF) is a detrimental process in CVD progression, currently lacking effective therapeutic strategies.
- Exosomes mediate intercellular communication via transported bioactive molecules, including microRNAs (miRNAs).
Purpose of the Study:
- To review the biological characteristics of exosomes and exosomal miRNAs.
- To explore the role and mechanisms of cell-derived exosomal miRNAs in myocardial fibrosis.
- To highlight the diagnostic and therapeutic potential of exosomal miRNAs for cardiac fibrosis.
Main Methods:
- Literature review focusing on exosomes, exosomal miRNAs, and myocardial fibrosis.
- Analysis of studies investigating miRNA involvement in cardiovascular diseases like coronary heart disease (CHD), atrial fibrillation (AF), and heart failure (HF).
- Exploration of exosomal miRNA functions in the pathogenesis of myocardial fibrosis.
Main Results:
- Exosomes serve as crucial mediators of intercellular communication in cardiovascular contexts.
- Specific exosomal miRNAs are implicated in the development and progression of myocardial fibrosis.
- MiRNAs demonstrate significant potential in the diagnosis and treatment of various cardiovascular diseases.
Conclusions:
- Exosomes and exosomal miRNAs play a pivotal role in myocardial fibrosis.
- Exosomal miRNAs offer promising avenues for the diagnosis and treatment of cardiac fibrosis.
- These vesicles hold potential as novel biotherapies and drug delivery systems for cardiovascular conditions.
Abstract:
Cardiovascular disease (CVD) stands as the foremost cause of patient mortality, and the lack of early diagnosis and defined treatment targets significantly contributes to the suboptimal prevention and management of CVD. Myocardial fibrosis (MF) is not only a complex pathogenic process with no effective treatment currently available but also exerts detrimental effects on the progression of various cardiovascular diseases, thereby escalating their mortality rates. Exosomes are nanoscale biocommunication vehicles that facilitate intercellular communication by transporting bioactive substances, such as nucleic acids and proteins, from specific cell types. Numerous studies have firmly established that microRNAs (miRNAs), as non-coding RNAs, wield post-transcriptional regulatory mechanisms and exhibit close associations with various CVDs, including coronary heart disease (CHD), atrial fibrillation (AF), and heart failure (HF). MiRNAs hold significant promise in the diagnosis and treatment of cardiovascular diseases. In this review, we provide a concise introduction to the biological attributes of exosomes and exosomal miRNAs. We also explore the roles and mechanisms of distinct cell-derived exosomal miRNAs in the context of myocardial fibrosis. These findings underscore the pivotal role of exosomes in the diagnosis and treatment of cardiac fibrosis and emphasize their potential as biotherapies and drug delivery vectors for cardiac fibrosis treatment.
Related Concept Videos
01:22MicroRNAs
01:36Overview of Exosomes
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...